Furukawa, Toshi A. http://orcid.org/0000-0003-2159-3776
Iwata, Susumu
Horikoshi, Masaru
Sakata, Masatsugu
Toyomoto, Rie
Luo, Yan
Tajika, Aran
Kudo, Noriko
Aramaki, Eiji
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP22de0107005)
Japan Society for the Promotion of Science (21K03049, 23K02915, 23K02935)
Article History
Accepted: 30 June 2023
First Online: 7 July 2023
Declarations
:
: TAF reports personal fees from Boehringer-Ingelheim, DT Axis, Kyoto University Original, Shionogi and SONY, and a grant from Shionogi, outside the submitted work; In addition, TAF has patents 2020-548587 and 2022-082495 pending, and intellectual properties for Kokoro-app licensed to Mitsubishi-Tanabe. SI is an employee of Life2Bits, Inc. AT received lecture fees from Sumitomo Dainippon Pharma, Eisai, Janssen Pharmaceutical, Meiji-Seika Pharma, Mitsubishi Tanabe Pharma, Otsuka, and Takeda Pharmaceutical. All the other authors have no conflict of interest to declare.
: Informed consent was obtained from all individuals who participated in the two trials and provided their thought records.
: No animal studies were carried out for his study.